Senate Panel Plans Nov. 17 Hearing On Califf Nomination; Key Journal Urges Confirmation

As the Senate health committee slates what is expected to be a smooth Nov. 17 confirmation hearing on President Barack Obama's pick to head FDA, stakeholders are lining up both strongly for and against Robert Califf's nomination. The New England Journal of Medicine in a recent editorial urged the Senate to confirm Califf, saying FDA needs a strong and experienced leader who can keep the agency focused on its mission. Industry groups along with a number of patient and...